(Press-News.org) Genetic mutations that lead to antiretroviral (the drugs used to treat HIV/AIDS) resistance in HIV-infected infants may develop as a result of exposure to low doses of maternal antiretroviral drugs via breastfeeding rather than being acquired directly from the mother. This key finding from a study by Clement Zeh from the US Centers for Disease Control and Prevention, Kisumu, Kenya, and colleagues, published in this week's PLoS Medicine, is important as it may impact the choice of drug regimen given to HIV-infected breastfeeding mothers and their infected infants—an effective intervention which has been shown to substantially reduce the overall rate of mother-to-child transmission of the HIV virus.
The authors conducted a secondary analysis (or substudy) of The Kisumu Breastfeeding Study—a trial in Kisumu, Kenya by Timothy Thomas and colleagues from the Kenya Medical Research Institute (KEMRI) and CDC, Kisumu, Kenya, and colleagues also reported in this week's PLoS Medicine. The Kisumu Breastfeeding Study assessed the safety and transmission rates of a triple-antiretroviral regimen (zidovudine, lamivudine, and either nevirapine or nelfinavir) given to HIV-infected women a few weeks before giving birth (34 wk gestation) through 6 months of breastfeeding. The study documented transmission rates of 7% at 24 months, most of them due to transmission in-utero or during delivery, which is considerably lower than the 25% - 48% transmission rates reported in the absence of antiretrovirals. The authors concluded that this combination of drugs was safe and feasible in resource-limited settings.
In their secondary analysis, Clement Zeh and colleagues investigated the possible causes of the emergence of maternal ARV-associated resistance among the 24 infants who were infected with HIV either at delivery or during 6 months of breastfeeding and thus exposed to maternal ARVs.
The authors took regular blood samples from these infants and from their mothers to look for the presence of HIV drug resistance mutations. The authors found that various mutations were present in samples taken from all the HIV-positive infants whose mothers who had received nelfinavir but in only half of those taken from infants whose mothers who had received nevirapine. However exposure to nevirapine resulted in a wider range of ARV resistant mutations. In contrast, most of the mothers of HIV-positive infants had no HIV drug resistance mutations, and only one mother-infant pair had an overlapping pattern of HIV drug resistance mutations. This pattern of mutations suggests that drug resistance most likely arose through exposure of the infants to low levels of ARVs in breast milk rather than through mother-to-child transmission of drug-resistant HIV virus.
These findings need further confirmation through future studies but suggest that infants exposed to antiretroviral drugs through breast milk—a situation that may become increasingly common given the encouraging results of The Kisumu Breastfeeding Study and similar trials that show a reduction in mother-to-child-transmission—should be carefully monitored for HIV infection. Providers should consider the mother's regimen when choosing treatment for infants who are found to be HIV infected while breastfeeding and closely monitor response to therapy.
Clement Zeh and colleagues say: "The low mother-to-child HIV transmission rates observed in the trial support the role of triple-combination maternal antiretroviral therapy as a successful [Prevention of Mother-to-Child Transmission] intervention among breastfeeding HIV-infected mothers. However, the data from this secondary analysis suggest that ingestion of antiretroviral drugs through breast milk may have contributed to the emergence of HIV drug resistance mutations in the infants, as we observed an increasing frequency of infants with HIV drug resistance mutations over the first 6 months of life when maternal antiretroviral therapy was given during breastfeeding."
They add: "[Prevention of Mother-to-Child Transmission] programs providing maternal antiretroviral therapy during breastfeeding and those caring for infants exposed to antiretroviral through breast milk will need to be cognizant of this issue and consider monitoring these infants more closely and tailoring their treatment accordingly."
###
Secondary Analysis by Zeh
Funding: This work was supported by the Kenya Medical Research Institute through a cooperative agreement with the US Centers for Disease Control and Prevention, Grant Award Number-5U19C1000323-05. Study drugs were provided by GlaxoSmithKline and Boehringer Ingelheim. Kenya Medical Research Institute and US Centers for Disease Control and Prevention investigators were involved with all aspects of study design, data collection, and analysis; interpretation of findings; report writing; and decision to submit the manuscript. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the US Centers for Disease Control and Prevention. Use of trade names is for identification purposes only and does not constitute endorsement by the US Centers for Disease Control and Prevention or the Department of Health and Human Services.
Competing Interests: The Academic Editor, Lynne Mofenson, has disclosed that she worked with authors Mary Glenn Fowler and Michael C. Thigpen on other projects unrelated to the study reported in this paper. The authors have no competing interests to declare.
Citation: Zeh C, Weidle PJ, Nafisa L, Lwamba HM, Okonji J, et al. (2011) HIV-1 Drug Resistance Emergence among Breastfeeding Infants Born to HIV-Infected Mothers during a Single-Arm Trial of Triple-Antiretroviral Prophylaxis for Prevention of Mother-To-Child Transmission: A Secondary Analysis. PLoS Med 8(3): e1000430. doi:10.1371/journal.pmed.1000430
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000430
PRESS-ONLY PREVIEW OF THE ARTICLE: www.plos.org/press/plme-08-03-zeh.pdf
Clinical Trial by Thomas
Funding: Funding for the study was provided by the Kenya Medical Research Institute (KEMRI) through a cooperative agreement with the US Centers for Disease Control and Prevention (CDC). Study drugs were provided by GlaxoSmithKline and Boehringer Ingelheim. The study design, data collection instruments, data collection, data analysis, decision to publish, and preparation of the manuscript were led by CDC and KEMRI staff based in Atlanta and at the KEMRI/CDC Field Station in Kisumu, Kenya. The companies that donated study drugs had an opportunity to review and comment on the manuscript, but otherwise did not have any role in the study. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the CDC. Use of trade names is for identification purposes only and does not constitute endorsement by the CDC or the Department of Health and Human Services. This publication has been approved by the Director of the Kenya Medical Research Institute.
Competing Interests: The Academic Editor, Lynne Mofenson, has disclosed that she worked with authors Mary Glenn Fowler and Michael C. Thigpen on other projects unrelated to the study reported in this paper. The authors have no competing interests to declare.
Citation: Thomas TK, Masaba R, Borkowf CB, Ndivo R, Zeh C, et al. (2011) Triple-Antiretroviral Prophylaxis to Prevent Mother-To-Child HIV Transmission through Breastfeeding—The Kisumu Breastfeeding Study, Kenya: A Clinical Trial. PLoS Med 8(3): e1001015. doi:10.1371/journal.pmed.1001015
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001015
PRESS-ONLY PREVIEW OF THE ARTICLE: www.plos.org/press/plme-08-03-thomas.pdf
Prevention of mother-child transmission programs work but infants need checking for drug resistance
2011-03-30
ELSE PRESS RELEASES FROM THIS DATE:
Next steps to making open access a global reality
2011-03-30
Two articles in this week's PLoS Medicine discuss the issues that need to be resolved to ensure that open access can provide for global information needs, and not just those of the developed world.
Leslie Chan, Barbara Kirsop, and Subbiah Arunachalam from the Electronic Publishing Trust for Development argue that access and distribution of public knowledge is currently governed by Northern standards, a situation that is increasingly inappropriate in what they call the "age of the networked Invisible College." Taking as a starting point that open access is sustainable ...
Scientists devise targeted therapy strategy for rare form of childhood cancer
2011-03-30
BOSTON--By "distracting" cancer proteins from their usual activity, scientists at Dana-Farber Cancer Institute and Brigham and Women's Hospital have caused cells in a rare, lethal form of cancer to begin behaving like normal cells -- one of the longest-standing, and most rarely achieved, goals of cancer research. The study's findings are published online by the journal Cancer Research and will appear later in a print issue.
When the approach was tested in a child with an advanced case of the malignancy, known as NUT midline carcinoma (NMC), it slowed the course of the ...
Elderly heart failure patients who need skilled nursing care often sicker, have poorer outcomes
2011-03-30
Elderly patients with heart failure who need skilled nursing care after hospital discharge are often sicker, at higher risk for poor outcomes and are more likely than other patients to die or be rehospitalized within one year, according to research reported in Circulation: Heart Failure, an American Heart Association journal.
"Patients hospitalized with heart failure are high risk to start with," said Larry A. Allen, M.D., M.H.S., lead author of the study and assistant professor of cardiology at the University of Colorado-Denver School of Medicine in Aurora. "If they ...
Moderate sleep and less stress may help with weight loss
2011-03-30
(PORTLAND, Ore.) March 29, 2011— If you want to increase your chances of losing weight, reduce your stress level and get adequate sleep. A new Kaiser Permanente study found that people trying to lose at least 10 pounds were more likely to reach that goal if they had lower stress levels and slept more than six hours but not more than eight hours a night.
The paper, published today in the International Journal of Obesity, was the result of a study funded by the National Institutes of Health's National Center for Complementary and Alternative Medicine.
Nearly 500 participants ...
Major report shows obese patients have double the risk of airway problems during an anesthetic
2011-03-30
A major UK study on complications of anaesthesia has shown that obese patients are twice as likely to develop serious airway problems during a general anaesthetic than non-obese patients. 'The airway' means the air passages from the outside world to the lungs, which must be kept open to keep the patient alive. The study also shows that the use of a simple breathing monitor, called a capnograph, could significantly reduce deaths and brain damage from such problems in intensive care units (ICUs); it found that absence of a capnograph contributed to 74% of deaths from these ...
Diabetes veterans may show ways to prevent complications
2011-03-30
BOSTON – March 29, 2011 – Over time, diabetes can wreak havoc on the body's eyes, cardiovascular system, kidneys and nerves. A major study by Joslin Diabetes Center researchers, however, has found that some people who have survived diabetes for many decades exhibit remarkably few complications—a discovery that points toward the presence of protective factors that guard against the disease's effects.
The scientists studied 351 participants in the Joslin 50-Year Medalist study, which examines people who have lived with type 1 diabetes for 50 years or more. Among this population, ...
UAB research targets way to stop brain tumor cell invasion
2011-03-30
BIRMINGHAM, Ala., - Gliomas are brain invaders. A kind of malignant tumor cell, gliomas branch out like tendrils from a central tumor source, spreading cancer throughout the brain. Traditional therapies, such as cutting out the tumor surgically, can be ineffective if the cells have already spread. Researchers at the University of Alabama at Birmingham may have come upon a way to stop a glioma invasion in its tracks, using a drug already approved for use in Europe.
Much like early explorers of the Old West followed rivers and streams, depending on them to provide drinking ...
Mothers abused during childhood at risk for having low birth weight babies
2011-03-30
Mothers who were maltreated as children have increased risk for giving birth to low birth weight babies. The findings, by researchers at the University of Washington, are the first to show that maternal maltreatment can affect the health of offspring.
The study also finds that childhood poverty and substance use during adolescence and pregnancy contribute to low birth weight, which is linked to infant mortality and chronic health problems.
"Our findings suggest that a mother's economic position in childhood and her experience of maltreatment during childhood have implications ...
Babies who sleep with smoker parents exhibit high nicotine levels
2011-03-30
"Third-hand smoke" stuck to skin or clothing is responsible for the high nicotine levels seen in babies who share a bedroom with their smoker parents. This is the conclusion of a study carried out in Catalonia, which also shows that ventilating bedrooms is not effective in reducing the levels of toxins from passive smoking.
"Passive smoking is the leading preventable cause of childhood death in developed countries", Guadalupe Ortega, lead author of the research study and coordinator of the Atenció Primària Sense Fum programme at the Department of Health of the Generalitat ...
MedWOW Upgrades Sales Leads Program
2011-03-30
MedWOW.com, the multilingual, global online marketplace for medical equipment, announces the launch of their upgraded sales leads program. All of the business leads generated are pre-qualified, registered buyers, looking for services and devices the merchants are offering. More than 10,500 medical equipment professionals visit the MedWOW site daily and transactions occur quickly and on a regular basis, so leads are kept fresh and current.
When purchasing leads credits, dealers now have the option of choosing money-saving discounted packages. The larger the package of ...